• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pakistan Pharmaceuticals and Healthcare Report Q1 2010 - Product Image

Pakistan Pharmaceuticals and Healthcare Report Q1 2010

  • Published: November 2009
  • Region: Pakistan
  • 85 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Abbott Laboratories
  • Ferozsons Laboratories
  • GlaxoSmithKline
  • Hilton Pharma
  • Merck & Co
  • Novartis
  • MORE

Business Monitor International's Pakistan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Pakistan's pharmaceuticals and healthcare industry.

In BMI’s Business Environment Ratings for Q110, Pakistan slipped from 13th to 15th – and last –place, out of the key markets assessed in the Asia Pacific region. In addition to the challenging economic environment, the country’s pharmaceutical expenditure will also be shaped by the volatile political and security situation. Overall, the publisher expects the pharmaceutical market value to increase at a compound annual growth rate (CAGR) of 9.39% in local currency terms, reaching PKR206.9bn (US$2.3bn) in 2014. Growth over the publisher's longer, 10-year, forecast is likely to be somewhat more subdued, at a CAGR of 8.75% in local currency, as the operating environment stabilises.

Although Pakistan’s pharmaceutical market opportunities are considerably underpinned by its vast and rapidly growing population, low per-capita READ MORE >

SWOT Analysis
- Pakistan Pharmaceutical Industry SWOT
- Pakistan Political SWOT
- Pakistan Economic SWOT
- Pakistan Business Environment SWOT

Pharmaceutical Business Environment Ratings
- Table: Asia Pacific Pharmaceutical Business Environment Ratings, Q110
- Limits Of Potential Returns
- Risks To Realisation Of Returns

Pakistan – Market Summary
- Regulatory Regime
- Recent Regulatory Developments
- Intellectual Property Regime
- Shortcomings of the Intellectual Property Environment
- Counterfeit Drugs
- Pricing and Reimbursement Regime
- Recent Pricing and Reimbursement Developments
- Industry Trends And Developments
- Epidemiology
- Non-Communicable Diseases
- Communicable Diseases
- Recent Public Health Developments

Healthcare System
- Table: Pakistan – Key Healthcare Statistics, 2007 (’000 people, unless otherwise stated)
- Healthcare Insurance
- Medical Tourism
- Traditional Medicine
- Retail Sector
- Research and Development
- International Co-operation
- Medical Devices

Industry Forecast Scenario
- Overall Market Forecast
- Key Growth Factors – Industry
- Key Growth Factors – Macroeconomic
- Table: Pakistan – Economic Activity, 2006-2013
- Prescription Market Forecasts
- Patented Product Market Forecast
- Generic Drug Market Forecast
- OTC Market Forecast
- Pharmaceutical Trade Forecasts
- Other Healthcare Data Forecasts
- Key Risks To BMI’s Forecast Scenario

Competitive Landscape
- Pharmaceutical Sector
- Domestic Pharmaceutical Industry
- Foreign Pharmaceutical Industry
- Recent Pharmaceutical Sector Developments

Company Monitor
- Leading Multinational Manufacturers
- GlaxoSmithKline (GSK)
- Pfizer
- Abbott Laboratories
- Novartis
- Sanofi-Aventis
- Merck & Co
- Wyeth
- Domestic Manufacturers
- Hilton Pharma
- Efroze Chemical Industries
- Ferozsons Laboratories
- Getz Pharma
- Pacific Pharmaceuticals

Country Snapshot: Pakistan Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education and Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Table: Employment Indicators, 2001-2006
- Section 3: Labour Market And Spending Power
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Manufacturing Wages, 2000-2012

BMI Methodology
- How Pharmaceutical Industry Forecasts Are Generated
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
- Forecast Tables

- GlaxoSmithKline
- Pfizer
- Abbott Laboratories
- Novartis
- Sanofi-Aventis
- Merck & Co
- Wyeth
- Hilton Pharma
- Efroze Chemical Industries
- Ferozsons Laboratories
- Getz Pharma Pacific Pharmaceuticals

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos